(Q37779496)

23 August 2017

Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort (English)

1 reference

23 August 2017

0 references

invasive aspergillosis

1 reference

14

1 reference

23 August 2017

J W Hiemenz

1

1 reference

23 August 2017

I I Raad

2

1 reference

23 August 2017

J A Maertens

3

1 reference

23 August 2017

R Y Hachem

4

1 reference

23 August 2017

A J Saah

5

1 reference

23 August 2017

C A Sable

6

1 reference

23 August 2017

J A Chodakewitz

7

1 reference

23 August 2017

M E Severino

8

1 reference

23 August 2017

P Saddier

9

1 reference

23 August 2017

R S Berman

10

1 reference

23 August 2017

D M Ryan

11

1 reference

23 August 2017

M J Dinubile

12

1 reference

23 August 2017

T F Patterson

13

1 reference

23 August 2017

T J Walsh

15

1 reference

23 August 2017

12 August 2010

1 reference

23 August 2017

8

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

inferred from page(s)

published in

1 reference

23 August 2017

29

1 reference

23 August 2017

11

1 reference

23 August 2017

1387-1394

1 reference

https://scigraph.springernature.com/pub.10.1007/s10096-010-1013-0

23 August 2017

0 references

cites work

The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10096-010-1013-0

Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure

21 January 2018

1 reference

12 December 2020

Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study

1 reference

12 December 2020

Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

1 reference

12 December 2020

Clinical trial design for invasive aspergillosis: time to cast a different mold

1 reference

12 December 2020

Randomized versus historical controls for clinical trials.

1 reference

12 December 2020

Salvage therapy with caspofungin for invasive aspergillosis: results from the caspofungin compassionate use study

1 reference

12 December 2020

Caspofungin as first-line therapy for the treatment of invasive aspergillosis after thoracic organ transplantation

1 reference

12 December 2020

Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: a randomized pilot study (Combistrat trial).

1 reference

12 December 2020

1 reference

12 December 2020

Trends in Risk Profiles for and Mortality Associated with Invasive Aspergillosis among Liver Transplant Recipients

1 reference

12 December 2020

High rate of invasive fungal infections following nonmyeloablative allogeneic transplantation

1 reference

12 December 2020

Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single-centre experience of 133 episodes in 116 patients

1 reference

12 December 2020

An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients

1 reference

12 December 2020

Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate

1 reference

12 December 2020

A comparison of observational studies and randomized, controlled trials

1 reference

12 December 2020

Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS.

1 reference

12 December 2020

Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy

1 reference

12 December 2020

NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis

1 reference

12 December 2020

Need for Alternative Trial Designs and Evaluation Strategies for Therapeutic Studies of Invasive Mycoses

1 reference

12 December 2020

Comparison of the dose-dependent activity and paradoxical effect of caspofungin and micafungin in a neutropenic murine model of invasive pulmonary aspergillosis

1 reference

12 December 2020

Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality

1 reference

12 December 2020

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

12 December 2020

Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group

1 reference

12 December 2020

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

1 reference

12 December 2020

An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis.

1 reference

12 December 2020

Efficacy of the echinocandin caspofungin against disseminated aspergillosis and candidiasis in cyclophosphamide-induced immunosuppressed mice

1 reference

12 December 2020

Comparison of 2 Studies of Treatment of Invasive Aspergillosis

1 reference

12 December 2020

Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices

1 reference

12 December 2020

A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis.

1 reference

12 December 2020

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

1 reference

12 December 2020

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

12 December 2020

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

1 reference

12 December 2020

Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)

1 reference

12 December 2020

Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin

1 reference

12 December 2020

Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis

1 reference

12 December 2020

Risk factors for invasive aspergillosis in liver transplant recipients

1 reference

12 December 2020

High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantation.

1 reference

12 December 2020

Invasive Aspergillosis in patients with acute leukemia: update on morbidity and mortality--SEIFEM-C Report

1 reference

12 December 2020

An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group

1 reference

12 December 2020

Predicting survival in adults with invasive aspergillosis during therapy for hematological malignancies or after hematopoietic stem cell transplantation: Single-center analysis and validation of the Seattle, French, and Strasbourg prognostic indexes

1 reference

12 December 2020

Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis

1 reference

12 December 2020

Invasive pulmonary aspergillosis in patients with hematologic malignancies: survival and prognostic factors

1 reference

12 December 2020

Multiple-Triazole–Resistant Aspergillosis

1 reference

12 December 2020

Counterpoint: alternative trial designs for antifungal drugs--time to talk

1 reference

12 December 2020

10.1007/S10096-010-1013-0

Identifiers

DOI

1 reference

23 August 2017

1 reference